2.53
+0(+0.00%)
Currency In USD
| Previous Close | 2.53 |
| Open | 2.52 |
| Day High | 2.54 |
| Day Low | 2.47 |
| 52-Week High | 2.63 |
| 52-Week Low | 1.51 |
| Volume | 100,342 |
| Average Volume | 282,119 |
| Market Cap | 149.19M |
| PE | -1.95 |
| EPS | -1.3 |
| Moving Average 50 Days | 2.07 |
| Moving Average 200 Days | 1.88 |
| Change | 0 |
If you invested $1000 in Seer, Inc. (SEER) since IPO date, it would be worth $44.81 as of December 04, 2024 at a share price of $2.53. Whereas If you bought $1000 worth of Seer, Inc. (SEER) shares 3 years ago, it would be worth $114.02 as of December 04, 2024 at a share price of $2.53.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Seer Ranked Number 57 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™
GlobeNewswire Inc.
Nov 21, 2024 9:05 PM GMT
Attributes 2,440% revenue growth to increased adoption of its Proteograph™ Product Suite and exciting discoveries made by Seer customers across multiple areas of biology and diseaseREDWOOD CITY, Calif., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Seer, Inc.
Seer to Participate in Upcoming November Investor Conferences
GlobeNewswire Inc.
Nov 08, 2024 12:00 PM GMT
REDWOOD CITY, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced company management will be participating in the following investor
Seer Reports Third Quarter 2024 Financial Results
GlobeNewswire Inc.
Nov 06, 2024 9:05 PM GMT
Growing enthusiasm for Proteograph Product Suite with multiple larger orders from government agencies and continued strong interest in STACREDWOOD CITY, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences co